Nevertheless, in human renal mesangial cells, circACTR2 aggravated under high-glucose conditions and activated the miR-205–5p/high-mobility group AT-hook 2 (HMGA2) axis, providing a novel target for the diagnostic and therapeutic potential of DKD treatment [129]. The gene discussed is HMGA2; the disease is diabetic kidney disease.